ReviewCell reports methods2022
Don't forget about human factors: Lessons learned from COVID-19 point-of-care testing.
Review in Cell reports methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- When Usability Isn't Enough: Understanding Rural Challenges in Respiratory Virus Test Interpretation.Diagnostics (Basel, Switzerland) · 2026Article
- Operational Validity in Decentralized Molecular Point-of-Care Diagnostics: A Human Factors Engineering Perspective.Diagnostics (Basel, Switzerland) · 2026Review
- Independent Testing to Accelerate the Development of Lateral Flow Assays for Influenza A, Influenza B and SARS-COV-2.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Point-of-care and Home Use Influenza Diagnostics for Advancing Therapeutic and Public Health Strategies.The Journal of infectious diseases · 2025Review
- A One-Pot RT-LAMP Diagnostic Assay for SARS-CoV‑2 from Saliva Samples.ACS measurement science au · 2025Article
- Current practices for assessing usability of novel point-of-care diagnostics for infectious diseases: a scoping review protocol.BMJ open · 2025Article
- Standardization of Microsampling Technologies for Accurate Sensing and Reliable Diagnostics.ACS sensors · 2025Review
- Implementation of Point-of-Care PCR-testing for the diagnosis of respiratory infections in vulnerable patient populations.PloS one · 2025Article
- Stakeholder perspectives on a hypothetical rapid test for antibiotic resistant bacteria: an exploratory study.Frontiers in antibiotics · 2025Article
- Accelerated Development of a COVID-19 Lateral Flow Test in an Academic Setting: Lessons Learned.Accounts of chemical research · 2024Article
- Advancing microfluidic point-of-care platelet function tests: opportunities and challenges from bench to market.Frontiers in bioengineering and biotechnology · 2024Review
- Selective Single-Molecule Nanopore Detection of mpox A29 Protein Directly in Biofluids.Nano letters · 2023Article
- The critical role of engineering in the rapid development of COVID-19 diagnostics: Lessons from the RADx Tech Test Verification Core.Science advances · 2023Review
- Stakeholders' views and experiences on implementing new diagnostics in primary care to support management of community-acquired acute respiratory tract infections: a qualitative study.Frontiers in public health · 2023Article
- Effect of swab pooling on the Accula point-of-care RT-PCR for SARS-CoV-2 detection.Frontiers in microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors.
Funding
Abstract
During the COVID-19 pandemic, the development of point-of-care (POC) diagnostic testing accelerated in an unparalleled fashion. As a result, there has been an increased need for accurate, robust, and easy-to-use POC testing in a variety of non-traditional settings (i.e., pharmacies, drive-thru sites, schools). While stakeholders often express the desire for POC technologies that are "as simple as digital pregnancy tests," there is little discussion of what this means in regards to device design, development, and assessment. The design of POC technologies and systems should take into account the capabilities and limitations of the users and their environments. Such "human factors" are important tenets that can help technology developers create POC technologies that are effective for end-users in a multitude of settings. Here, we review the core principles of human factors and discuss lessons learned during the evaluation process of SARS-CoV-2 POC testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.